Who owns MANGOCEUTICALS INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Mangoceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Mangoceuticals stock

Who bought or sold MANGOCEUTICALS INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 490k $362k 155% Dec 2025
 View chart
Geode Capital Management 195k $70k 80% Mar 2026
 View chart
Ikarian Capital 138k $50k 0% Mar 2026
 View chart
Vanguard Capital Management 123k $44k 100% Mar 2026
 View chart
Jane Street 73k $26k 53% Mar 2026
 View chart
Vanguard Fiduciary Trust 57k $21k 100% Mar 2026
 View chart
Boothbay Fund Management 38k $14k 0% Mar 2026
 View chart
Northern Trust 38k $28k 98% Dec 2025
 View chart
Ackerman Capital Advisors 35k $12k 0% Mar 2026
 View chart
Virtu Financial 34k $25k 100% Dec 2025
 View chart
Intl Fcstone 16k $5.8k 100% Mar 2026
 View chart
Sunbelt Securities 12k $4.3k 0% Mar 2026
 View chart
Goldman Sachs Group 12k $4.2k 100% Mar 2026
 View chart
Csenge Advisory Group 10k $3.6k 0% Mar 2026
 View chart
Advisor Group Holdings 2.9k $2.1k 0% Dec 2025
 View chart
Fortitude Family Office 1.3k $484.017200 255% Mar 2026
 View chart
Tower Research Capital 1.0k $740.979000 100% Dec 2025
 View chart
Morgan Stanley 1.0k $360.000000 0% Mar 2026
 View chart

Who sold out of Mangoceuticals?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Dec 2025 46k $34k
XTX Topco Sep 2025 29k $62k